Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,765 INR | -1.33% | +1.84% | -8.23% |
Feb. 27 | Gland Pharma Names New President of Phixen Subsidiary | MT |
Feb. 15 | Jefferies Adjusts Gland Pharma’s Price Target to INR2,400 From INR2,250, Keeps at Buy | MT |
Sales 2024 * | 56.59B 682M | Sales 2025 * | 63.32B 764M | Capitalization | 294B 3.55B |
---|---|---|---|---|---|
Net income 2024 * | 8.67B 105M | Net income 2025 * | 11.06B 133M | EV / Sales 2024 * | 4.71 x |
Net cash position 2024 * | 27.46B 331M | Net cash position 2025 * | 31.74B 383M | EV / Sales 2025 * | 4.15 x |
P/E ratio 2024 * |
33.9
x | P/E ratio 2025 * |
26.6
x | Employees | 4,585 |
Yield 2024 * |
0.1% | Yield 2025 * |
0.19% | Free-Float | 37.15% |
Latest transcript on Gland Pharma Limited
1 day | -1.33% | ||
1 week | +1.84% | ||
Current month | +0.03% | ||
1 month | -11.79% | ||
3 months | -4.81% | ||
6 months | +4.96% | ||
Current year | -8.23% |
Managers | Title | Age | Since |
---|---|---|---|
Srinivas Sadu
CEO | Chief Executive Officer | 54 | 99-12-31 |
Director of Finance/CFO | - | 19-09-29 | |
C. S. Venkatesan
CTO | Chief Tech/Sci/R&D Officer | - | 97-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 22-03-09 |
Srinivas Sadu
CEO | Chief Executive Officer | 54 | 99-12-31 |
Yiu Kwan Lau
CHM | Chairman | 69 | 19-06-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-19 | 1,765 | -1.33% | 4 302 |
24-03-18 | 1,789 | +0.44% | 5,962 |
24-03-15 | 1,781 | +1.91% | 5,337 |
24-03-14 | 1,748 | +3.37% | 16,897 |
24-03-13 | 1,691 | -2.46% | 23,945 |
Delayed Quote Bombay S.E., March 19, 2024 at 03:04 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.83% | 687B | |
+30.96% | 595B | |
+0.01% | 378B | |
+15.18% | 316B | |
+11.39% | 308B | |
+0.78% | 211B | |
-6.09% | 208B | |
-2.92% | 203B | |
-3.72% | 157B |
- Stock
- Equities
- Stock Gland Pharma Limited
- Stock Gland Pharma Limited - Bombay S.E.